VYNE Therapeutics
VYNE
VYNE
104 hedge funds and large institutions have $138M invested in VYNE Therapeutics in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 105 → 104 (-1)
5% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 19
Holders
104
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.39M | |
| 2 | +$3.31M | |
| 3 | +$946K | |
| 4 |
Squarepoint
New York
|
+$791K |
| 5 |
State Street
Boston,
Massachusetts
|
+$783K |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$581K | |
| 3 | -$352K | |
| 4 |
Morgan Stanley
New York
|
-$251K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$233K |